Cipla

Cipla Limited
Cipla
FormerlyChemical Industrial & Pharmaceutical Laboratories Ltd. (1935–1984)
TypePublic
BSE: 500087
NSE: CIPLA
NSE NIFTY 50 constituent
ISININE059A01026
IndustryPharmaceuticals
Founded1935 (1935)
FounderKhwaja Abdul Hamied
HeadquartersMumbai, Maharashtra, India
Area served
Worldwide
Key people
Products
RevenueIncrease ₹27,548 crore (US$2.9 billion) (2025)
Increase ₹7,128 crore (US$740 million) (2025)
Increase ₹5,273 crore (US$550 million) (2025)
Total assetsIncrease ₹37,387 crore (US$3.9 billion) (2025)
Total equityIncrease ₹31,289 crore (US$3.2 billion) (2025)
Number of employees
27,764 (March 2024)
SubsidiariesInvagen Pharmaceuticals
Websitewww.cipla.com
Footnotes
Financials as of 31 March 2025.

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.